Announcements Trials
Browse Landscape

Status

Recruiting 13Active not recruiting 11Completed 8Withdrawn 4Terminated 4Not yet recruiting 1No longer available 1Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Neoplasms by Site 1Neoplasms 1Breast Neoplasms 1Breast Diseases 1Brain Neoplasms 1

Interventions

veliparib 2tucatinib 1pegilodecakin 1palbociclib 1leronlimab 1iniparib 1glembatumumab vedotin 1Vinorelbine 1Letrozole 1Everolimus 1Cisplatin 1Alpelisib 1Ado-Trastuzumab Emtansine 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × tucatinib × Breast × Clear all
NCT03424473 2020-02-25

Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer

Seagen Inc.

No longer available
BreastCNS

Brain Neoplasms, Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡